Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide.

MLA

La Vecchia, Maria, et al. “Stereotactic Body Radiotherapy in Oligoprogressive Metastatic Castration-Resistant Prostate Cancer during Abiraterone or Enzalutamide.” Tumori, vol. 109, no. 4, Aug. 2023, pp. 413–17. EBSCOhost, https://doi.org/10.1177/03008916221132592.

APA

La Vecchia, M., Fazio, I., Borsellino, N., Lo Casto, A., & Galanti, D. (2023). Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide. Tumori, 109(4), 413–417. https://doi.org/10.1177/03008916221132592

Chicago

La Vecchia, Maria, Ivan Fazio, Nicolò Borsellino, Antonio Lo Casto, and Daniele Galanti. 2023. “Stereotactic Body Radiotherapy in Oligoprogressive Metastatic Castration-Resistant Prostate Cancer during Abiraterone or Enzalutamide.” Tumori 109 (4): 413–17. doi:10.1177/03008916221132592.